Thermo Fisher Scientific (TMO) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $706.16 +1.12%
Financial Fact:
Restructuring and other costs, net: 54.9M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Restructuring and other costs, net: 54.9M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $5.03, in-line with the analyst estimate of $5.03. Revenue for the quarter came in at $10.71 billion versus the consensus estimate of $10.65 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Stabilis Solutions, Inc. (SLNG) Tops Q3 EPS by 3c
- eHealth (EHTH) Misses Q3 EPS by 45c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
